3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
37
Sleep Initiation and Maintenance Disorders
1
Salivary Gland Neoplasms
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Neoplasm Metastasis
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castrate-sensitive Prostate Cancer
1
Low Risk Prostate Cancer
1
Fatigue
1
Depression
1
Adenocarcinoma
1
Interventions
olaparib
1
gallium 68 PSMA-11
1
Pluvicto
1
Gemcitabine
1
Cisplatin
1
Androgen Antagonists
1
Adrenal Cortex Hormones
1
Abiraterone Acetate
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Genital Neoplasms, Male
×
apalutamide
×
90 days
×
Clear all
No trials found.